Average Profit Margin
The latest reported profit margin is 11.96% as of Tuesday, March 31, 2026, shown against its trailing averages.
PODD Average Profit Margin
PODD Profit Margin Averages
PROFIT MARGIN LATEST REPORTED
11.96%
PROFIT MARGIN TTM
9.40%
PROFIT MARGIN 3Y
11.30%
PROFIT MARGIN 5Y
9.02%
PROFIT MARGIN 10Y
2.38%
PROFIT MARGIN 15Y
-4.94%
PROFIT MARGIN 20Y
-10.29%
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy